1-5 of 5
Authors: Yves Lévy
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV Get access
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 6, June 2012, Pages 1449–1452, https://doi.org/10.1093/jac/dks045
Published: 05 March 2012
Journal Article
Comparative activity of carbapenem testing: the COMPACT study Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1070–1078, https://doi.org/10.1093/jac/dkr056
Published: 08 March 2011
Journal Article
IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy—results from the ANRS CO4 cohort Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 10, October 2010, Pages 2215–2223, https://doi.org/10.1093/jac/dkq296
Published: 11 August 2010
Journal Article
Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial Get access
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 5, November 2008, Pages 1122–1129, https://doi.org/10.1093/jac/dkn309
Published: 28 July 2008
